Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, dedicated to the development of transformative therapies for neuropsychiatric and neurodegenerative disorders. The company is focused on addressing significant unmet medical needs by leveraging cutting-edge science and technology to innovate treatment strategies targeted at critical biological pathways associated with complex brain diseases. With a robust pipeline of novel compounds, Neumora aspires to enhance patient outcomes and redefine standards of care in neurology.
Click "Analyze" to generate stock analysis
NMRA Price Trend and Signals
NMRA Option Volumes & Open Interests (aggregated)
NMRA Put Call Ratios and IV (aggregated)
NMRA Financials
2025-10-30Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-30Bullishprice_signal
Large price change detected: 17.2%.
2025-10-30Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-30Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-30Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-10-27Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-24Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-23Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-23Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.